Harpoon Therapeutics, Inc. (HARP) NASDAQ

23.01

+0.02(+0.09%)

Updated at March 08, 2024 04:00PM

Currency In USD

Valuation

Market Cap24.08M
Enterprise Value-11.53M
P/E Ratio-1.14
PEG Ratio-0.01
Price/Sales Ratio27.11
Price/Book Ratio14.14
Enterprise/Revenue25.99
Enterprise/EBITDA-12.57

Fiscal Year

Fiscal YearDecember 31, 2022
Most Recent QuarterSeptember 30, 2023

Profitability

Profit Margin-2.1
Operating Margin-2.14

Management Effectiveness

Return On Assets-0.91
Return On Equity-2.12

Income Statement

Revenue31.92M
Revenue/Share9.62
Gross Profit28.82M
EBITDA-65.97M
Net Income-67.14M
Diluted EPS-20.24

Balance Sheet

Total Cash31.61M
Total Cash/Share16.01
Total Debt14.5M
Total Debt/Equity2.96
Current Ratio1.04
Book Value Per Share1.63

Price History

52-Week Change257.3
52-Week High23.21
52-Week Low3.11
Moving Average 50 Days20.73
Moving Average 200 Days10.76

Statistics

Average Volume1.13M
Shares Outstanding37.6M
% Held by Institutions47.09

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:10
Last Split DateSeptember 05, 2023